CClinicalTrials.gg
Not yet recruitingNCT05812703Updated May 7, 2024

Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain

An observational study in Chronic Pain and Sedentary Time, sponsored by Stanford University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-05-07.

Sponsored by Stanford University · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2025, 11 months ago, but the record still lists the study as not yet recruiting.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years and older
Sex
All
01

Study summary

The study will provide important information regarding the biometric changes that occur in behavioral treatments for chronic pain and explore the additional impact of integrated movement and supervised exercise. The goal of this clinical trial is to determine if pain rehabilitation programs have impacts on physical function in patient reported outcomes and objective measures of physical activity or sedentary time with a wearable Fitbit. Additionally, we will examine the associations between movement, pain acceptance, and related health factors, such as pain severity, sleep, functional status, depression, and anxiety. The addition of biometric data will allow for further investigation of the association between objective measures and patient self-report measures.

Read the detailed description

Chronic pain has high impact on societal function as well as an individual person's mood, physical function, disability, and quality of life and their health. The purpose of the study is to collect objective outcome measures on movement, activity, biometrics and patient reported outcome measures for participants of behavioral treatment groups of 6-8 weeks duration at Stanford Pain Management Center. Group participants learn skills and develop a personalized plan to use the skills throughout the program. The study will follow participants with a removable wearable device on the wrist for 2 weeks pre group to establish movement activity baselines, during the group intervention (6-8 weeks) and 2 weeks post group to determine which groups have benefits across various aspects of health including: sleep, psychological processes of pain acceptance, physical mobility, quality of life and the impact of supervised movement and physical activity in the treatment groups.

02

Conditions studied

  • Chronic Pain
  • Sedentary Time

Browse trials for

Keywords

  • movement
  • behavioral treatments
  • biometrics
  • chronic pain
03

In context

Chronic Pain

2,930 studies on the registry are indexed under Chronic Pain; 701 are open to participants now.

This study's planned enrollment of 50 is below the median of 126 across 688 observational studies indexed under Chronic Pain.

Browse Chronic Pain studies →

Lead sponsor

Stanford University is the lead sponsor of 2,117 studies on the registry; 425 are open to participants now.

Of its 259 completed or terminated interventional studies of FDA-regulated products, 197 (76%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Participants with chronic pain

Inclusion criteria

  1. Age 18+
  2. Non-cancer chronic pain (pain that occurs on at least half of the days of 6 months or more)
  3. English fluency
  4. Ability to attend >70% treatment sessions to ensure active treatment is delivered

Exclusion criteria

Exclusion Criteria:

  1. Cognitive impairment, non-English speaking, or psychological factors that would preclude comprehension of material and/or full participation in the study.
  2. Participants with acute cauda equina syndrome
  3. Inability to complete a 6 minute walk test without LOB
  1. Chronic pain as explained by inflammatory disease

For the movement-based portions of group:

Exclusion: For our CBT + Movement (low intensity/ restorative) movement group: Patient must be able to sit upright for 20 minutes without loss of balance or upper extremity (UE) assistance. Inability to sit without use of UE support would be excluded. This ensures safety that the participant can completed the adapted movement program without risk of falls. HR will not be elevated > 50% HRmax in these restorative movement classes.

Exclusion criteria for the Back in ACTion (higher intensity) movement group is inability to complete a 6-minute walk test safely or without loss of balance, as this poses a fall risk that requires individual assistance throughout the class, or medical exclusion from cardiovascular exercise over 50% HRmax, as HR will be elevated to 50-70% HR max in these classes.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Target follow-up
8 Months
Patient registry
Yes
Biospecimen retention
Samples without dna

Groups and cohorts

  • Behavioral Group Treatment (Cognitive Behavioral Therapy CBT + Movement)

    Cognitive Behavioral Therapy Group led by a psychologist to learn pain coping skills, with gentle movement component of duration from 45 minutes to 60 minutes under a licensed Healthcare provider (PT or OT).

    Behavioral: Cognitive Behavioral Therapy

  • Behavioral Group Treatment (ACT) only

    Acceptance and Commitment Therapy Group led by a psychologist to learn skills to change their relationship with pain to decrease pain's impact on their life.

    Behavioral: Acceptance and Commitment Therapy (ACT)

  • Behavioral Group Treatment (ACT + Movement)- Back in ACTion

    Acceptance and Commitment Therapy Group led by a psychologist to learn skills to change their relationship with pain to decrease pain's impact on their life and improve willingness to engage in valued activities. Movement component to last from with intense and gentle movement sessions with a total movement time of 90 minutes - 2 hours led by licensed health care provider a PT or OT.

    Behavioral: Acceptance and Commitment Therapy (ACT) · Behavioral: Moderate to high Intensity Group Exercise

Interventions

  • BehavioralCognitive Behavioral Therapy

    The participants will attend one of the behavioral group treatments programs offered by the Stanford Pain Management Center. This class may be held online via Zoom, or in person based at the Stanford Pain Management Center. The class may be recorded for training purposes. No names or images/faces will be recorded for privacy reasons. The behavioral groups are 3 types, with or without exercise/movement. Current Evidence Based treatments that are provided as standard practice include: Cognitive Behavioral Therapy Group, with movement, Acceptance and Commitment Therapy Group, with or without movement. Group participants will learn different skills in each group and develop a personalized plan to use the skills after group ends. At the end of group participants will be given an anonymous survey about the class to evaluate satisfaction of the treatment. Movement in this portion of class is designed to low impact and restorative/gentle, with no significant increases in HR \> 50% HRmax.

    Also known as: Pain Coping Skills, Group Movement

  • BehavioralAcceptance and Commitment Therapy (ACT)

    ACT is a 6 week behavioral group program led by a psychologist to improve psychological flexibility and reduce pain interference in patients with chronic pain.

  • BehavioralModerate to high Intensity Group Exercise

    Group exercise led by supervised clinician with Cardiovascular focus to increase HR into zones to see adaptations to improve cardiovascular fitness.

06

What researchers measure

Primary outcomes

  1. Change in sedentary behavior time

    Sedentary behavior is defined as any waking behavior such as sitting or leaning with an energy expenditure of 1.5 metabolic equivalent task (MET) or less

    Time frame: Pre intervention (baseline), and post intervention (at 10 weeks)

Secondary outcomes

  1. HF-Heart rate variability

    Heart rate variability (per participant) is where the amount of time between your heartbeats fluctuates slightly. Even though these fluctuations are undetectable except with specialized devices, they can still indicate current or future health problems, including heart conditions and mental health issues like anxiety and depression. Heart rate variability (in milliseconds) has no standard reference range. HF is the high frequency band of HRV.

    Time frame: Pre intervention (baseline), end of treatment session (week 6), and post intervention (at 10 weeks)

  2. Sleep Duration

    Amount of time asleep per "night cycle"

    Time frame: Pre intervention (baseline), end of treatment session (week 6), and post intervention (at 10 weeks)

  3. Daily Step Count

    Amount of steps occurring in a 24 hour day

    Time frame: Pre intervention (baseline), end of treatment session (week 6), and post intervention (at 10 weeks)

  4. Pain Catastrophizing

    13-item self-report measure designed to assess catastrophic thinking related to pain among adults. The score ranges from 0-52, where higher scores indicate greater pain catastrophizing.

    Time frame: Pre intervention (baseline), and post intervention (at 10 weeks) and 6 months follow up (post group)

  5. PROMIS Depression Score

    Self reported Questionnaires to assess depression. Patient-Reported Outcomes Measurement Information System (PROMIS) - Depression use a T-score metric, and the scores range from 10T to 85T, with the population mean score of 50T (SD of 10). Higher T scores would indicate worse symptom in each domain.

    Time frame: Pre intervention (baseline), and post intervention (at 10 weeks),and 6 months follow up (post group)

  6. PROMIS Anxiety Score

    Self reported Questionnaires to assess anxiety. Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety measures use a T-score metric, and the scores range from 10T to 85T, with the population mean score of 50T (SD of 10). Higher T scores would indicate worse symptom in each domain.

    Time frame: Pre intervention (baseline), and post intervention (at 10 weeks),and 6 months follow up (post group)

  7. PROMIS Sleep Disturbance Score

    Self reported Questionnaires to assess sleep quality. Patient-Reported Outcomes Measurement Information System (PROMIS) , Sleep Disturbance use a T-score metric, and the scores range from 10T to 85T, with the population mean score of 50T (SD of 10). Higher T scores would indicate worse symptom in each domain.

    Time frame: Pre intervention (baseline), and post intervention (at 10 weeks),and 6 months follow up (post group)

  8. PROMIS Physical Function Score

    Self reported Questionnaires to assess physical function/mobility. Patient-Reported Outcomes Measurement Information System (PROMIS) physical function measures use a T-score metric, and the scores range from 10T to 85T, with the population mean score of 50T (SD of 10). Higher T scores would indicate worse symptom in each domain.

    Time frame: Pre intervention (baseline), and post intervention (at 10 weeks),and 6 months follow up (post group)

  9. PROMIS Pain Interference Score

    Self-reported Questionnaires to assess pain interference. Patient-Reported Outcomes Measurement Information System (PROMIS), pain interference, and physical function measures use a T-score metric, and the scores range from 10T to 85T, with the population mean score of 50T (SD of 10). Higher T scores would indicate worse symptom in each domain.

    Time frame: Pre intervention (baseline), and post intervention (at 10 weeks),and 6 months follow up (post group)

  10. Duration of Heart Rate in Exercise Zones (50-70% HRMax) (during exercise)

    The time in a 24 hour period that the participant has an elevated heartrate for sustained duration indicating exercise. We would want to increase our amount of time (minutes) in HRzones to indicate more time spend in active exercise during the movement portions of the interventions.

    Time frame: Pre intervention (baseline), and post intervention (at 10 weeks)

  11. Average Resting Heartrate

    A 2013 study in the journal Heart tracked the cardiovascular health of about 3,000 men for 16 years and found that a high resting heart rate was linked with lower physical fitness and higher blood pressure, body weight, and levels of circulating blood fats. The researchers also discovered that the higher a person's resting heart rate, the greater the risk of premature death. Specifically, an RHR between 81 and 90 doubled the chance of death, while an RHR higher than 90 tripled it. A low resting heart rate often suggests greater physical fitness. A reduction in average resting heart rate would indicate improvement in CV fitness for our treatment interventions.

    Time frame: Pre intervention (baseline), end of treatment session (week 6), and post intervention (at 10 weeks)

  12. Physical Activity Vital Sign

    the subjective measure of minutes a person is physically active in a week (in minutes)

    Time frame: Pre intervention (baseline), end of treatment session (week 6), and post intervention (at 10 weeks)

07

Study locations

1 site
  • Stanford Pain Management Clinic
    Redwood City, California 94061, United States
08

References and documents

Publications

  • You DS, Ziadni MS, Cooley CE, Talavera DC, Mackey SC, Poupore-King H. Effectiveness of a multidisciplinary rehabilitation program in real-world patients with chronic back pain: A pilot cohort data analysis. J Back Musculoskelet Rehabil. 2021;34(6):965-973. doi: 10.3233/BMR-200305. PubMed 34151829 ↗
  • Neumann A, Hampel P. Long-term effects of rehabilitation and prevention of further chronification of pain among patients with non-specific low back pain. J Back Musculoskelet Rehabil. 2022;35(6):1257-1268. doi: 10.3233/BMR-210221. PubMed 35754259 ↗
  • Pears S, Sutton S. Effectiveness of Acceptance and Commitment Therapy (ACT) interventions for promoting physical activity: a systematic review and meta-analysis. Health Psychol Rev. 2021 Mar;15(1):159-184. doi: 10.1080/17437199.2020.1727759. Epub 2020 Feb 17. PubMed 32036768 ↗
  • Mercer K, Li M, Giangregorio L, Burns C, Grindrod K. Behavior Change Techniques Present in Wearable Activity Trackers: A Critical Analysis. JMIR Mhealth Uhealth. 2016 Apr 27;4(2):e40. doi: 10.2196/mhealth.4461. PubMed 27122452 ↗
  • Shaffer F, Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017 Sep 28;5:258. doi: 10.3389/fpubh.2017.00258. eCollection 2017. PubMed 29034226 ↗
  • Karayannis NV, Sturgeon JA, Kemani MK, Mackey SC, Greco CM, Wicksell RK, McCracken LM. Pain acceptance and psychological inflexibility predict pain interference outcomes for persons with chronic pain receiving pain psychology. Scand J Pain. 2023 Feb 7;23(3):464-475. doi: 10.1515/sjpain-2022-0107. Print 2023 Jul 26. PubMed 36745187 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 7, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05812703
Lead sponsor
Stanford University
Responsible party
Heather Poupore-King (Clinical Associate Professor, Stanford University) — Principal investigator
First posted
Apr 14, 2023
Start date
Sep 27, 2024 (estimated)
Primary completion
Oct 25, 2025 (estimated)
Completion
Apr 25, 2026 (estimated)
Last update
May 7, 2024

Study contacts

Heather King, PhD
principal investigator · Stanford University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion